A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

  • David I. Bernstein, Judith Falloon, Tingting Yi
  • Vaccine, September 2011, Elsevier
  • DOI: 10.1016/j.vaccine.2011.07.031

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/j.vaccine.2011.07.031